Charles Bancroft makes quick leap from Bristol Myers exec team to GSK; Medicxi adds two new partners to its team
→ Just a few days after Bristol Myers reported that Charles Bancroft had “retired” from the executive team, he’s made a quick career shift to the board at GlaxoSmithKline. GSK reported today that Bancroft is taking a non-executive director post at the giant pharma outfit. He’s slated to chair GSK’s audit & risk committee. Bancroft has extensive commercial and strategy experience in the business.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.